Jun 16, 2020 The U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to the Strategic National Stockpile to be used to treat certain hospitalized patients with COVID-19…


May 21, 2020 Regulators from around the world have agreed three priority areas for cooperation on observational research during COVID-19. They will collaborate on pregnancy research, on medicines used in clinical practice and on vaccine safety and effectiveness monitoring.…

February 28, 2020 The U.S. Food and Drug Administration has approved an application for the first generic of Daraprim (pyrimethamine) tablets for the treatment of toxoplasmosis (an infection caused by the parasite Toxoplasma gondii) when used with a sulfonamide (a…
Recent Post
- 🚨 CDSCO Issues Urgent Directive for Stopping manufacturing and marketed of Unapproved FDCs – What Pharma Manufacturers Need to Know
- 📊 Unlocking Opportunity: Comprehensive Market Research Reports Now Available at Vaayath Consulting
- 🌐Ease of Doing Business: CDSCO introduces new Updates regarding the Auto-generated Market standard Certificate (MSC) and Non-Conviction Certificate (NCC) for Licenced Medical devices.
- Complete List of Banned Drugs in India
- Government Mandates Online CRO Registration via SUGAM Portal!